Search results
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 4 hours agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
Fortune· 2 hours agoIn the first quarter of the year, Moderna reported $167 million in sales of its only product on the market, its COVID-19 vaccine called Spikevax. The company’s first quarter ...
Moderna ends gene editing alliance with Metagenomi
BioPharma Dive via Yahoo Finance· 12 hours agoMetagenomi said the companies’ decision to part ways followed a “strategic prioritization” undertaken by Moderna, which has made several investments in...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 13 hours agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Moderna makes several cost-cutting moves, leans into AI - Boston Business Journal
The Business Journals· 10 hours agoModerna and Metagenomi framed the news as a mutual decision, and Moderna said it “continues to...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 7 hours agoOne analyst called the results "transformational." And Moderna stock surged more than 9% on Dec. 19,...
Moderna to seek parity for RSV shot (NASDAQ:MRNA)
Seeking Alpha· 6 hours agoModerna (MRNA) stock gains as the company highlights its upcoming RSV shot, expecting the U.S. regulators to endorse it on par with rival products. Read more here.
J.P. Morgan downgrades Metagenomi over Moderna deal termination (NASDAQ:MGX)
Seeking Alpha· 6 hours agoJ.P. Morgan has lowered its rating of Metagenomi (NASDAQ:MGX) to neutral, citing the recent...
Moderna Focused on Cutting Costs, RSV Vaccine
Bloomberg· 9 hours agoModerna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
NBC Philadelphia· 13 hours agoModerna posted a narrower-than-expected loss for the first quarter as the company's cost-cutting...
